Condensed Consolidated Statements of Changes In Stockholders’ (Deficit) Equity (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2019	$ 14	$ 206,569	$ 85,907,523	$ (89,036,271)	$ (2,922,165)
Balance (in Shares) at Dec. 31, 2019	13,602	206,569,062
Stock-based compensation			439,956		439,956
Common stock issued on exercise of warrant		$ 25	1,725		1,750
Common stock issued on exercise of warrant (in Shares)		25,000
Sale of common stock		$ 3,710	1,109,290		1,113,000
Sale of common stock (in Shares)		3,710,000
Net loss				(1,265,091)	(1,265,091)
Balance at Mar. 31, 2020	$ 14	$ 210,304	87,458,494	(90,301,362)	(2,632,550)
Balance (in Shares) at Mar. 31, 2020	13,602	210,304,062
Balance at Dec. 31, 2020	$ 14	$ 190,529	93,778,591	(92,266,764)	1,702,370
Balance (in Shares) at Dec. 31, 2020	13,602	190,529,320
RSU restricted Stock		$ 31	4,519		4,550
RSU restricted Stock (in Shares)		31,250
Stock-based compensation			170,029		170,029
Common stock issued on exercise options and warrant		$ 1,606	40,394		42,000
Common stock issued on exercise options and warrant (in Shares)		1,605,682
Common stock issued on exercise of convertible note		$ 158	47,340		47,499
Common stock issued on exercise of convertible note (in Shares)		158,329
Sale of common stock		$ 7,056	2,250,944		2,258,000
Sale of common stock (in Shares)		7,056,250
Net loss				(1,086,438)	(1,086,438)
Balance at Mar. 31, 2021	$ 14	$ 199,381	$ 96,291,817	$ (93,353,202)	$ 3,138,010
Balance (in Shares) at Mar. 31, 2021	13,602	199,380,831